文献速递脑血管病癫痫

老年卒中幸存者新发癫痫与难治性癫痫的风险

The risk of new-onset epilepsy and refractory epilepsy in older adult stroke survivors.
PubMed 文献 · Neurology · 2019-07-10

本研究基于加拿大安大略省卒中登记数据库,纳入19138例67岁及以上因卒中住院的老年患者,分析新发癫痫和难治性癫痫的相关因素及诊断护理与死亡情况。结果显示1.1%的患者发生癫痫,其中12.9%为难治性癫痫,癫痫诊断后5年内46.2%死亡。

要点

  • 老年卒中幸存者新发癫痫风险较低,1.1%发生癫痫,12.9%为难治性癫痫。
  • 年轻年龄和溶栓治疗显著增加癫痫风险,较轻卒中严重程度和抗凝药使用也增加风险但效应随时间减弱。
  • 癫痫诊断后5年内46.2%死亡,86.6%的死因归因于卒中或癫痫以外的原因。

核心结论

  • 老年卒中幸存者发生癫痫和药物难治性癫痫的可能性较低。
  • 新发癫痫的老年卒中幸存者中约86.6%的死亡归因于卒中或癫痫以外的原因。

研究设计与样本

  • 基于人群的回顾性队列研究,使用关联的行政医疗数据库。
  • 通过安大略省卒中登记识别2003年4月1日至2009年3月31日在指定卒中中心住院且既往无癫痫的67岁及以上卒中患者。
  • 采用多变量Fine-Gray风险模型分析癫痫和难治性癫痫的风险因素,并考虑死亡竞争风险。

主要发现

  • 19138例老年卒中住院患者中,210例(1.1%)发生癫痫,27例(12.9%)对抗癫痫药物难治。
  • 癫痫诊断后1年内,24例(11.4%)接受EEG评估,19例(9.0%)接受MRI评估。
  • 多变量分析中,年轻年龄和接受溶栓治疗显著增加癫痫风险;较轻卒中严重程度和接受抗凝药物也显著增加癫痫风险,但这些效应随时间减弱。
  • 年轻年龄和女性是难治性癫痫的唯一风险因素。
  • 癫痫诊断后5年内,97例(46.2%)参与者因任何原因死亡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Our study objectives were to identify factors associated with new-onset epilepsy and refractory epilepsy among older adult stroke survivors and to evaluate the receipt of diagnostic care and mortality for participants who developed epilepsy. METHODS: We conducted a population-based, retrospective cohort study using linked, administrative health care databases. The Ontario Stroke Registry was used to identify patients 67 years and older who were hospitalized for a stroke at a designated stroke center in Ontario, Canada, between April 1, 2003, and March 31, 2009, and were previously free of epilepsy. Multivariable Fine-Gray hazard models were used to examine risk factors of epilepsy and refractory epilepsy, accounting for the competing risk of death. RESULTS: Among 19,138 older adults hospitalized for a stroke, 210 (1.1%) developed epilepsy and 27 (12.9%) became refractory to antiepileptic drugs. Within 1 year of epilepsy diagnosis, 24 (11.4%) patients were assessed with EEG and 19 (9.0%) with MRI. In multivariable analysis, younger age and thrombolysis receipt significantly increased epilepsy risk. Lesser stroke severity and anticoagulant medication receipt also significantly increased epilepsy risk; however, these effects decreased over time. Younger age and female sex were the only risk factors of refractory epilepsy. In the 5 years following epilepsy diagnosis, 97 (46.2%) participants died of any cause. CONCLUSIONS: Older adult stroke survivors are less likely to develop epilepsy and pharmacologically refractory epilepsy. An estimated 86.6% of deaths among older adult stroke survivors with new-onset epilepsy are attributed to causes other than stroke or epilepsy.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Burneo JG, Antaya TC, Allen BN, et al. The risk of new-onset epilepsy and refractory epilepsy in older adult stroke survivors. Neurology. 2019. PMID: 31292225. doi:10.1212/WNL.0000000000007895

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。